Yang W G, Chan C Y, Lu C L, Tsay S H, Lee S D
Department of Medicine, Veterans General Hospital-Taipei, Taiwan, R.O.C.
Zhonghua Yi Xue Za Zhi (Taipei). 1995 Jan;55(1):64-8.
We described a patient with history of chronic hepatitis B in whom cholestatic hepatitis occurred after amoxicillin/clavulanic acid (Augmentin) therapy, which to our knowledge is the first case reported in Asia. An atypical serology profile of hepatitis B virus (HBV) markers, demonstrated by negative hepatitis B surface antigen (HBsAg) associated with transient positivity of hepatitis B e antigen (HBeAg) and HBV DNA, was noted during the development of cholestasis.
我们描述了一名有慢性乙型肝炎病史的患者,该患者在接受阿莫西林/克拉维酸(奥格门汀)治疗后发生了胆汁淤积性肝炎,据我们所知,这是亚洲报道的首例此类病例。在胆汁淤积形成过程中,发现了乙型肝炎病毒(HBV)标志物的非典型血清学特征,表现为乙型肝炎表面抗原(HBsAg)阴性,同时乙型肝炎e抗原(HBeAg)和HBV DNA短暂阳性。